Incyte CEO on New Drugs, Jakafi Applications

Feb. 20 (Bloomberg) -- Herve Hoppenot, chief executive officer of Incyte Corp., talks with Bloomberg’s Meg Tirrell about the company's Jakfi drug used to treat a bone marrow disorder called myelofibrosis, Incyte's drug pipeline and the outlook for growth. Shares of the cancer-drug maker have tripled in the last year. (Source: Bloomberg)
Kleiner Decision on Pao Not Gender Based
57:30 - Brad Stone and Janine Yancey discuss the verdict of the Kleiner-Pao case. They speak with Pimm Fox on "Taking Stock." (Source: Bloomberg)
  • Kleiner Not Guilty of Retaliation
  • Yellen Sees Gradual Rate Increases Starting This Year
  • Kleiner Decision Not Gender Based